Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

News Daily News

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

L.A. McKeown

December 12, 2024

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Opinion CV Team Dispatch

July 2024 Dispatch for the CV Team

L.A. McKeown

July 01, 2024

News Conference News SCAI 2024

No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis

L.A. McKeown

May 10, 2024

News Daily News

FDA Approves Bioresorbable Scaffold for BTK Lesions

Michael O'Riordan

April 29, 2024

News Conference News ACC 2024

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

Caitlin E. Cox

April 10, 2024

News Conference News ISET 2024

How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy

Caitlin E. Cox

January 24, 2024

News Daily News

JACC Statement Focuses on PAD Disparities, Gaps in Care

L.A. McKeown

December 04, 2023

News Daily News

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

L.A. McKeown

July 11, 2023

News Daily News

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

L.A. McKeown

July 11, 2023

News Conference News SCAI 2023

Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI

L.A. McKeown

May 24, 2023

News Daily News

Only Half of Revascularized PAD Patients Receive GDMT

L.A. McKeown

February 14, 2023

News Conference News AHA 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

L.A. McKeown

November 07, 2022

News Conference News VIVA 2021

EMINENT: Better Patency With DES Over BMS for Fem-Pop Lesions

L.A. McKeown

October 12, 2021

News Daily News

Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years

L.A. McKeown

September 17, 2020

News Daily News

DCB Match DES Through 1 Year in Femoropopliteal Lesions, DRASTICO Affirms

Caitlin E. Cox

July 11, 2019

News Conference News SCAI 2019

Paclitaxel DCBs and CHIP: SCAI Kicks Off With Two Hot-Potato Topics

Yael L. Maxwell

May 21, 2019

News Daily News

Signal of Late Deaths With Paclitaxel-Coated DCBs and Stents for PAD Warrants Urgent Review, Authors Say

L.A. McKeown

December 07, 2018

News Conference News ISET 2017

Underappreciated by Clinicians, Critical Limb Ischemia Has Dire Fallout for Patients

Caitlin E. Cox

February 07, 2017

News Industry News

Boston Scientific Announces FDA Approval of Innova™ Vascular Self-Expanding Stent System

August 19, 2015

Advertisement

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

Scientific Statement Reviews Current Antithrombotic Options in PAD

July 2024 Dispatch for the CV Team

No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis

FDA Approves Bioresorbable Scaffold for BTK Lesions

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy

JACC Statement Focuses on PAD Disparities, Gaps in Care

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI

Only Half of Revascularized PAD Patients Receive GDMT

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

EMINENT: Better Patency With DES Over BMS for Fem-Pop Lesions

Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years

DCB Match DES Through 1 Year in Femoropopliteal Lesions, DRASTICO Affirms

Paclitaxel DCBs and CHIP: SCAI Kicks Off With Two Hot-Potato Topics

Signal of Late Deaths With Paclitaxel-Coated DCBs and Stents for PAD Warrants Urgent Review, Authors Say

Underappreciated by Clinicians, Critical Limb Ischemia Has Dire Fallout for Patients

Boston Scientific Announces FDA Approval of Innova™ Vascular Self-Expanding Stent System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content